Cocaine embryofetopathy

A group of clinical signs observed in newborns exposed in utero to cocaine, a short-acting central nervous system stimulant used as a recreational drug through inhalation of the powder or intravenous injection. Cocaine use during pregnancy is associated with intrauterine growth restriction, low birth weight, seizures, respiratory distress (decreased apnea density and periodic breathing), feeding difficulties, irritability and lability of state, decreased behavioral and autonomic regulation, poor alertness and orientation and cognitive impairment (impaired auditory information processing , visual-spatial delay and subtle language delay) in the offspring.

Also known as: fetal cocaine syndrome, foetal cocaine syndrome, cocaine antenatal exposure, cocaine fetopathy, prenatal cocaine exposure

4 clinical trials for this condition and its sub-types.